Human Peripheral Blood CD14+ Monocytes, Cryopreserved, Negative Selection, 50 million
Human Peripheral Blood CD14+ Monocytes, Cryopreserved, Negative Selection, 50 million
Cryopreserved ampule of negatively selected Human Peripheral Blood CD14+ Monocytes, containing ≥ 50 million cells
Product Overview
CD14+ monocytes are negatively selected from leukapheresed peripheral blood MNCs using an immunomagnetic labeling system to remove unwanted cell types.
Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using hemacytometer (trypan blue method). Cells are collected from healthy donors following IRB protocols.
Request More InfoBenefits
- Cells are isolated from peripheral blood obtained from a healthy donor
- HIV-1, Hepatitis B and Hepatitis C are not detected for all donors and/or cell lots
- Certificate of Analysis (CoA) is provided for each cell lot purchased
Applications
- Generate monocyte-derived M1 and M2 macrophages or dendritic cells
- Dendritic cell differentiation and maturation
- Inflammatory studies
- Toll-like receptor and pattern recognition receptors (PRR)
- Phagocytosis
- Metabolism mechanisms
Storage and Content
1 x Cryopreserved ampule of CD14+ Monocytes containing ≥ 50 million cells
SDS, CoA, and Instructions
Safety Data Sheets (SDS)
Choose a language to view the SDS.
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
